These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15107193)

  • 1. No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity.
    van der Post J; de Waal PP; de Kam ML; Cohen AF; van Gerven JM
    J Psychopharmacol; 2004 Mar; 18(1):109-14. PubMed ID: 15107193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vestibular compensation is affected by treatment with dopamine active agents.
    Petrosini L; Dell'Anna ME
    Arch Ital Biol; 1993 Apr; 131(2-3):159-71. PubMed ID: 8101705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers.
    Mehta MA; Hinton EC; Montgomery AJ; Bantick RA; Grasby PM
    J Psychopharmacol; 2005 Jan; 19(1):29-38. PubMed ID: 15671126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous eye blinks are entrained by finger tapping.
    Cong DK; Sharikadze M; Staude G; Deubel H; Wolf W
    Hum Mov Sci; 2010 Feb; 29(1):1-18. PubMed ID: 19913931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to sulpiride in social anxiety disorder: D2 receptor function.
    Bell C; Bhikha S; Colhoun H; Carter F; Frampton C; Porter R
    J Psychopharmacol; 2013 Feb; 27(2):146-51. PubMed ID: 22745189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats.
    Desai RI; Neumeyer JL; Bergman J; Paronis CA
    Behav Pharmacol; 2007 Dec; 18(8):745-54. PubMed ID: 17989512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers.
    Barrett SL; Bell R; Watson D; King DJ
    J Psychopharmacol; 2004 Jun; 18(2):156-72. PubMed ID: 15260903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of eye solutions on blinking and ocular comfort at rest and during work at video display terminals.
    Acosta MC; Gallar J; Belmonte C
    Exp Eye Res; 1999 Jun; 68(6):663-9. PubMed ID: 10375429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic temporal variation in the rate of spontaneous eye blinking in human infants.
    Bacher LF; Smotherman WP
    Dev Psychobiol; 2004 Mar; 44(2):140-5. PubMed ID: 14994265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstruction of eye movements during blinks.
    Baptista MS; Bohn C; Kliegl R; Engbert R; Kurths J
    Chaos; 2008 Mar; 18(1):013126. PubMed ID: 18377077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.
    Lawrence MS; Redmond DE
    Pharmacol Biochem Behav; 1991 Apr; 38(4):869-74. PubMed ID: 1678527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D2-subtype of dopaminergic receptors is involved in anxiety behavior in ovariectomized rats].
    Fedotova IuO
    Patol Fiziol Eksp Ter; 2008; (3):10-3. PubMed ID: 18942469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinking and schizotypal thinking.
    Mohr C; Sándor PS; Landis T; Fathi M; Brugger P
    J Psychopharmacol; 2005 Sep; 19(5):513-20. PubMed ID: 16166189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol as an indicator of dopaminergic effects on nicotine craving.
    Reuter M; Hennig J
    Hum Psychopharmacol; 2003 Aug; 18(6):437-46. PubMed ID: 12923821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence.
    Schmidt LG; Kuhn S; Smolka M; Schmidt K; Rommelspacher H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):209-17. PubMed ID: 11817496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
    Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state.
    te Beek ET; Zoethout RW; Bani MS; Andorn A; Iavarone L; Klaassen ES; Fina P; van Gerven JM
    J Psychopharmacol; 2012 Feb; 26(2):303-14. PubMed ID: 22219221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor mechanisms in the expression of conditioned fear.
    de Oliveira AR; Reimer AE; Brandão ML
    Pharmacol Biochem Behav; 2006 May; 84(1):102-11. PubMed ID: 16780936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.